Literature DB >> 11032938

Evaluation of inflammatory cytokines in malignant and benign pleural effusions.

M G Alexandrakis1, S A Coulocheri, D Bouros, K Mandalaki, N Karkavitsas, G D Eliopoulos.   

Abstract

We measured the levels of inflammatory cytokines interleukin-1alpha (IL-1alpha), interleukin-1beta (IL-1beta), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) in pleural effusions and serum in 65 consecutive patients: 32 with malignant pleural effusion (MPE) (group A), and 33 with inflammatory benign pleural effusion (BPE) (group B). Serum levels of 15 healthy individuals served as control. Concentrations of IL-1alpha were higher in serum compared to pleural fluid in both groups (47.1+/-33.9 vs. 25.9+/-1.7 fmol/ml, p<0.001, in group A; and 39.9+/-30.9 vs. 25.4+/-16.3 fmol/ml, p<0.02, in group B). Similarly, concentrations of IL-1beta and IL-2 were significantly higher in serum compared to pleural fluid in both groups. In contrast, IL-6, IL-8 and TNF-alpha were found at high concentration in MPE in comparison to serum IL-6: 171.8+/-60.4 vs. 7. 2+/-7 fmol/ml (p<0.001), IL-8: 1175.15+/-2385.6 vs. 285.2+/-187.2 pg/ml (p<0.05), TNF-alpha: 204.9+/-82.9 vs. 79.4+/-31.9 fmol/ml (p<0. 001). Similarly, pleural concentrations of IL-6, IL-8 and TNF-alpha were higher in BPE patients in comparison to serum IL-6: 124.3+/-56. 2 vs. 8.6+/-6.4 fmol/ml (p<0.001) IL-8: 2109.2+/-4121.5 vs. 291. 6+/-197.9 pg/ml (p<0.02), TNF-alpha: 183.8+/-28.2 vs. 86.2+/-23.9 fmol/ml (p<0.001). These data suggest that IL-6, IL-8 and TNF-alpha might be secreted locally at the site of active disease both in benign and malignant pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032938     DOI: 10.3892/or.7.6.1327

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

Authors:  S C Chen; W Chen; W H Hsu; Y H Yu; C M Shih
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

2.  Primary human mesothelial cell culture in the evaluation of the inflammatory response to different sclerosing agents used for pleurodesis.

Authors:  Michal Mierzejewski; Magdalena Paplinska-Goryca; Piotr Korczynski; Rafal Krenke
Journal:  Physiol Rep       Date:  2021-04

3.  Aromatic-aromatic interactions: analysis of π-π interactions in interleukins and TNF proteins.

Authors:  Vaideeswaran Sivasakthi; Parimelzaghan Anitha; Kalavathi Murugan Kumar; Susmita Bag; Padmanaban Senthilvel; Pandian Lavanya; Rayapadi Swetha; Anand Anbarasu; Sudha Ramaiah
Journal:  Bioinformation       Date:  2013-04-30

4.  Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.

Authors:  Hsuan-Heng Yeh; Wen-Tsan Chang; Kuang-Chu Lu; Wu-Wei Lai; Hsiao-Sheng Liu; Wu-Chou Su
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

5.  The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.

Authors:  D J McKeown; D J F Brown; A Kelly; A M Wallace; D C McMillan
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.